第 1 到 119 筆結果,共 119 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2015 | A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients | MING-KAI CHUANG ; Chiu, Y.-C.; WEN-CHIEN CHOU ; HSIN-AN HOU ; ERIC YAO-YU CHUANG ; HWEI-FANG TIEN | Leukemia | 46 | 48 | |
2 | 2017 | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes | CHI-YUAN YAO ; Chen, Ching-Hsuan; HUAI-HSUAN HUANG ; HSIN-AN HOU ; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Kao, Chein-Jun; TZU-PIN LU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood advances | 16 | 15 | |
3 | 2007 | Acquisition and cure of autoimmune disease following allogeneic hematopoietic stem cell transplantation | HSIN-AN HOU ; JIH-LUH TANG ; SZU-CHUN HSU ; CHIA-LI YU ; YAO-CHANG CHEN ; MING YAO | Journal of the Formosan Medical Association | 4 | 4 | |
4 | 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen, Chien-Yuan ; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 55 | 51 | |
5 | 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 284 | 255 | |
6 | 2023 | Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis | Tseng, Chi-Yang; Fu, Yu-Hsuan; DA-LIANG OU ; Lu, Jeng-Wei; HSIN-AN HOU ; LIANG-IN LIN | Cancer gene therapy | 0 | 0 | |
7 | 2017 | Aurora A and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFA | Wei T.-Y.W.; Wu P.-Y.; Wu T.-J.; HSIN-AN HOU ; WEN-CHIEN CHOU ; Teng C.-L.J.; Lin C.-R.; Chen J.-M.M.; Lin T.-Y.; Su H.-C.; Huang C.-C.F.; Yu C.-T.R.; Hsu S.-L.; HWEI-FANG TIEN ; Tsai M.-D. | Cancer Research | 39 | 33 | |
8 | 2009 | Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival | TIFFANY TING-FANG SHIH ; HSIN-AN HOU ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; Chen H.-Y.; Wei S.-Y.; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; WOEI TSAY ; CHIH-WEI YU ; CHAO-YU HSU ; HWEI-FANG TIEN ; PAN-CHYR YANG | Blood | 70 | 60 | |
9 | 2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
10 | 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 | |
11 | 2010 | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | HSIN-AN HOU ; TIFFANY TING-FANG SHIH ; Liu C.-Y.; BANG-BIN CHEN ; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; CHAO-YU HSU ; HWEI-FANG TIEN | Haematologica | 14 | 14 | |
12 | 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Yu-Hung Wang; HSIN-AN HOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; CHI-YUAN YAO ; CHIA-LANG HSU ; Mei-Hsuan Tseng; CHENG-HONG TSAI ; Yen-Ling Peng; Chein-Jun Kao; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood advances | 15 | 15 | |
13 | 2022 | The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression | CHI-YUAN YAO ; CHIEN-CHIN LIN ; Wang, Yu-Hung; Hsu, Chia-Lang; Kao, Chein-Jun; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
14 | 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
15 | 2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 124 | 100 | |
16 | 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | CHENG-HONG TSAI ; JIH-LUH TANG ; FENG-MING TIEN ; YUAN-YEH KUO ; Wu D.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; CHIA-WEN LIU ; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood Advances | 32 | 27 | |
17 | 2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
18 | 2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 59 | 42 | |
19 | 2022 | Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma | Hsu C.-J.; HSIN-AN HOU ; CHANG-PING LIN ; Lee Y.-J.; Hsu W.-F.; PO-TING YEH | Journal of the Formosan Medical Association | 1 | 1 | |
20 | 2016 | Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection | WEI-LI MA ; HSIN-AN HOU ; Hsu, Ya-Jui; YIN-KAI CHEN ; JIH-LUH TANG ; WOEI TSAY ; PO-TING YEH ; CHUNG-MAY YANG ; CHANG-PING LIN ; HWEI-FANG TIEN | Annals of Hematology | 43 | 37 | |
21 | 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
22 | 2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | HSIN-AN HOU ; Lu J.-W.; Lin T.-Y.; CHENG-HONG TSAI ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; JIH-LUH TANG ; Gong Z.; LIANG-IN LIN ; HWEI-FANG TIEN | Blood cancer journal | 15 | ||
23 | 2023 | Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; FENG-MING TIEN ; Lo, Min-Yen; Ni, Sao-Chih; MING YAO ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 3 | |
24 | 2016 | Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia | Madan V.; Shyamsunder P.; Han L.; Mayakonda A.; Nagata Y.; Sundaresan J.; Kanojia D.; Yoshida K.; Ganesan S.; Hattori N.; Fulton N.; Tan K.-T.; Alpermann T.; Kuo M.-C.; Rostami S.; Matthews J.; Sanada M.; Liu L.-Z.; Shiraishi Y.; Miyano S.; Chendamarai E.; HSIN-AN HOU ; Malnassy G.; Ma T.; Garg M.; Ding L.-W.; Sun Q.-Y.; Chien W.; Ikezoe T.; Lill M.; Biondi A.; Larson R.A.; Powell B.L.; Lübbert M.; Chng W.J.; HWEI-FANG TIEN ; Heuser M.; Ganser A.; Koren-Michowitz M.; Kornblau S.M.; Kantarjian H.M.; Nowak D.; Hofmann W.-K.; Yang H.; Stock W.; Ghavamzadeh A.; Alimoghaddam K.; Haferlach T.; Ogawa S.; Shih L.-Y.; Mathews V.; Koeffler H.P. | Leukemia | 96 | 64 | |
25 | 2011 | Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; JIH-LUH TANG ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; HWEI-FANG TIEN | British Journal of Cancer | 32 | 28 | |
26 | 2017 | The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model | Hsu Y.-C.; Chiu Y.-C.; CHIEN-CHIN LIN ; Kuo Y.-Y.; HSIN-AN HOU ; Tzeng Y.-S.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Hsiao T.-H.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Journal of Hematology and Oncology | 37 | 32 | |
27 | 2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 181 | 173 | |
28 | 2021 | Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHIA-LANG HSU ; SHENG-YU HUNG ; CHI-YUAN YAO ; Lee, Sze-Hwei; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Annals of hematology | 21 | 19 | |
29 | 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
30 | 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 6 | 6 | |
31 | 2022 | Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Wang, Yu-Hung; CHI-YUAN YAO ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hsu, Cheng-An; Sun, Hsun-I; Chuang, Yi-Kuang; Hsu, Chia-Lang; FENG-MING TIEN ; Tsai, Cheng-Hong; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Hematological oncology | 0 | 0 | |
32 | 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
33 | 2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 197 | 184 | |
34 | 2011 | Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission | BANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; HSIN-AN HOU ; Liu C.-Y.; Wei S.-Y.; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; TIFFANY TING-FANG SHIH | Radiology | 40 | 29 | |
35 | 2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 31 | 25 | |
36 | 2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | ||
37 | 2022 | Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 5 | 4 | |
38 | 2022 | Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015 | HSIN-AN HOU ; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Chien, Li-Nien | Annals of hematology | 1 | 1 | |
39 | 2015 | Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis | Jung C.W.; Shih L.-Y.; Xiao Z.; Jie J.; HSIN-AN HOU ; Du X.; Wang M.-C.; Park S.; Eom K.-S.; Oritani K.; Okamoto S.; Tauchi T.; Kim J.S.; Zhou D.; Saito S.; Li J.; Handa H.; Jianyong L.; Ohishi K.; Hou M.; Depei W.; Takenaka K.; Liu T.; Hu Y.; Amagasaki T.; Ito K.; Gopalakrishna P.; Akashi K. | Leukemia and Lymphoma | 24 | 23 | |
40 | 2022 | Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015 | Chien, Li-Nien; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; HSIN-AN HOU | Journal of the Formosan Medical Association = Taiwan yi zhi | 6 | 2 | |
41 | 2018 | Epidemiology of multiple myeloma in Taiwan, a population based study | Tang C.-H.; Liu H.-Y.; HSIN-AN HOU ; Qiu H.; KUAN-CHIH HUANG ; Siggins S.; Rothwell L.A.; Liu Y. | Cancer Epidemiology | 24 | ||
42 | 2023 | Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia | YI-TSUNG YANG ; CHI-YUAN YAO ; PO-JU CHIU ; Kao, Chein-Jun; HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | American journal of hematology | 1 | 1 | |
43 | 2021 | The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes | SHENG-YU HUNG ; CHIEN-CHIN LIN ; CHIA-LANG HSU ; CHI-YUAN YAO ; Wang, Yu-Hung; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 4 | 4 | |
44 | 2008 | Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; MING YAO ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN | Leukemia Research | 57 | 50 | |
45 | 2014 | Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma | SHANG-YI HUANG ; CHUNG-WU LIN ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; YAO-CHANG CHEN ; Lu H.-Y.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; WOEI TSAY ; Chou S.-J.; HWEI-FANG TIEN | Annals of Hematology | 53 | 48 | |
46 | 2018 | Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation | Nagase R.; Inoue D.; Pastore A.; Fujino T.; HSIN-AN HOU ; Yamasaki N.; Goyama S.; Saika M.; Kanai A.; Sera Y.; Horikawa S.; Ota Y.; Asada S.; Hayashi Y.; Kawabata K.C.; Takeda R.; HWEI-FANG TIEN ; Honda H.; Abdel-Wahab O.; Kitamura T. | Journal of Experimental Medicine | 104 | 92 | |
47 | 2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | HSIN-AN HOU ; YUN-CHU LIN ; Kuo Y.-Y.; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Annals of Hematology | 21 | 20 | |
48 | 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | ||
49 | 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Liu, C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; LIANG-IN LIN ; WOEI TSAY ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; HWEI-FANG TIEN | Leukemia | 101 | 90 | |
50 | 2019 | Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): An international study on 331 patients | Christen F.; Hoyer K.; Yoshida K.; HSIN-AN HOU ; Waldhueter N.; Heuser M.; Hills R.K.; Chan W.; Hablesreiter R.; Blau O.; Ochi Y.; Klement P.; WEN-CHIEN CHOU ; Blau I.-W.; JIH-LUH TANG ; Zemojtel T.; Shiraishi Y.; Shiozawa Y.; Thol F.; Ganser A.; Löwenberg B.; Linch D.C.; Bullinger L.; Valk P.J.M.; HWEI-FANG TIEN ; Gale R.E.; Ogawa S.; Damm F. | Blood | 86 | 78 | |
51 | 2014 | Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells | Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Hsiao M.; HWEI-FANG TIEN | Journal of Leukocyte Biology | 18 | 14 | |
52 | 2023 | High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHI-YUAN YAO ; Amaral, Fabio M R; SHAN-CHI YU ; Kao, Chein-Jun; Shih, Pin-Tsen; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood advances | 4 | 3 | |
53 | 2017 | High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia | Lee, Sze-Hwei; Chiu, Yu-Chiao; Li, Yi-Hung; CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncotarget | 18 | 19 | |
54 | 2015 | High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan | JIH-LUH TANG ; HSIANG-CHI KUNG ; Lei W.-C.; MING YAO ; UN-IN WU ; SZU-CHUN HSU ; Lin C.-T.; Li C.-C.; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG ; BOR-SHENG KO ; HWEI-FANG TIEN | PLoS ONE | 48 | 42 | |
55 | 2015 | Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study | SHANG-YI HUANG ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; Lu H.-Y.; WOEI TSAY ; HWEI-FANG TIEN | PLoS ONE | 10 | 9 | |
56 | 2017 | Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia | CHIEN-CHIN LIN ; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; HSIN-AN HOU ; KENG-HSUEH LAN ; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 30 | 30 | |
57 | 2023 | Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target | Wang, Yu-Hung; CHIEN-CHIN LIN ; Gurashi, Kristian; Wingelhofer, Bettina; Amaral, Fabio M R; CHI-YUAN YAO ; Hsieh, Hsin Ting; Liu, Ming Chih; HSIN-AN HOU ; WEN-CHIEN CHOU ; Batta, Kiran; Wiseman, Daniel H; Tien, Hwei-Fang | Leukemia | 0 | 0 | |
58 | 2022 | Higher RUNX1 expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patients | Wang, Yu-Hung; CHI-YUAN YAO ; CHIEN-CHIN LIN ; CHI-LING CHEN ; CHIA-LANG HSU; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | EJHaem | 0 | ||
59 | 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
60 | 2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 75 | 69 | |
61 | 2022 | Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Chia-Lang; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 2 | 2 | |
62 | 2011 | The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies | YIN-KAI CHEN ; HSIN-AN HOU ; Chow J.-M.; YEE-CHUN CHEN ; PO-REN HSUEH ; HWEI-FANG TIEN | European Journal of Clinical Microbiology and Infectious Diseases | 40 | 36 | |
63 | 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | CHENG-HONG TSAI ; CHI-YUAN YAO ; FENG-MING TIEN ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | EBioMedicine | 21 | 22 | |
64 | 2018 | Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome | HSIN-AN HOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; LIANG-IN LIN ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | Blood Cancer Journal | 62 | 59 | |
65 | 2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 77 | 73 | |
66 | 2022 | Interpretation of Biomarkers in Fever of Unknown Origin-demonstration in A Clinical Case | Hsiao, Yu Chung; Sun, Kuo Jui; SZU-MIN HSIEH ; HSIN-AN HOU | Journal of Internal Medicine of Taiwan | 0 | 0 | |
67 | 2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
68 | 2020 | Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan | Liu Y.; HSIN-AN HOU ; Qiu H.; Tang C.-H. | Scientific Reports | 6 | 5 | |
69 | 2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
70 | 2020 | Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice | CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Yueh-Chwen; HSIN-AN HOU ; CHANG-TSU YUAN ; Li, Yi-Hung; Kao, Chein-Jun; Chuang, Po-Han; Chiu, Yu-Chiao; Chen, Yidong; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 14 | 12 | |
71 | 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
72 | 2023 | Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma | Chieh-Lung Cheng ; PO-TING YEH ; Fang, Wei-Quan; WEI-LI MA ; HSIN-AN HOU ; Tsai, Cheng-Hong; CHANG-PING LIN ; HWEI-FANG TIEN | Cancer medicine | 1 | 0 | |
73 | 2023 | Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group | Gill, Harinder; Leung, Garret M K; Ooi, Melissa G M; Teo, Winnie Z Y; Wong, Chieh-Lee; Choi, Chul Won; Wong, Gee-Chuan; Lao, Zhentang; Rojnuckarin, Ponlapat; Castillo, Ma Rosario Irene D; Xiao, Zhijian; HSIN-AN HOU ; Kuo, Ming-Chung; Shih, Lee-Yung; Gan, Gin-Gin; CHIEN-CHIN LIN ; Chng, Wee-Joo; Kwong, Yok-Lam | Clinical and experimental medicine | 0 | 0 | |
74 | 2018 | Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information | Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; JIH-LUH TANG ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; HWEI-FANG TIEN ; HSIN-AN HOU | Mayo Clinic Proceedings | 18 | 19 | |
75 | 2020 | MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria | Yassin M.A.; Taher A.; Mathews V.; HSIN-AN HOU ; Shamsi T.; Tuğlular T.F.; Xiao Z.; Kim S.-J.; Depei W.; Li J.; Rippin G.; Sadek I.; Siddiqui A.; Wong R.S. | Cancer Medicine | 29 | 30 | |
76 | 2014 | MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia | Ko Y.-C.; WOEI-HORNG FANG ; Lin T.-C.; HSIN-AN HOU ; Chen, Chien-Yuan ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia Research | 10 | 10 | |
77 | 2023 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study | Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kiladjian, Jean-Jacques; Granacher, Nikki; Lee, Sung-Eun; Ocroteala, Luminita; Passamonti, Francesco; Harrison, Claire N; Klencke, Barbara J; Ro, Sunhee; Donahue, Rafe; Kawashima, Jun; Mesa, Ruben; HSIN-AN HOU | Lancet (London, England) | 51 | ||
78 | 2022 | MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia | Mesa, Ruben; Komatsu, Norio; Gill, Harinder; Jin, Jie; Lee, Sung-Eun; HSIN-AN HOU ; Sato, Toshiaki; Qin, Albert; Urbanski, Raymond; Shih, Weichung; Zagrijtschuk, Oleh; Zimmerman, Craig; Verstovsek, Srdan | Clinical lymphoma, myeloma & leukemia | 3 | 3 | |
79 | 2015 | An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype | MING-KAI CHUANG ; Chiu Y.-C.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Tseng M.-H.; Kuo Y.-Y.; Chen Y.; Chuang E.Y.; HWEI-FANG TIEN | Oncotarget | 39 | 40 | |
80 | 2014 | The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression | YUAN-YEH KUO ; HSIN-AN HOU ; YIN-KAI CHEN ; Li, Li-Yu; Chen, Po-Hsuen; Tseng, Mei-Hsuan; Huang, Chi-Fei; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen; WEN-CHIEN CHOU ; Liu, Chieh-Yu; JIH-LUH TANG ; MING YAO ; HWEI-FANG TIEN | Haematologica | 10 | 10 | |
81 | 2019 | Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis | McGraw K.L.; Cheng C.-H.; Chen Y.A.; HSIN-AN HOU ; Nilsson B.; Genovese G.; Cluzeau T.; Pellagatti A.; Przychodzen B.P.; Mallo M.; Arenillas L.; Mohamedali A.; Adès L.; Sallman D.A.; Padron E.; Sokol L.; Moreilhon C.; Raynaud S.; HWEI-FANG TIEN ; Boultwood J.; Ebert B.L.; Sole F.; Fenaux P.; Mufti G.J.; Maciejewski J.P.; Kanetsky P.A.; List A.F. | Blood Advances | 6 | 5 | |
82 | 2022 | Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair | Chen, Tsung-Chih; CHI-YUAN YAO ; Chen, Yu-Ren; CHANG-TSU YUAN ; CHIEN-CHIN LIN ; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 2 | 2 | |
83 | 2017 | Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD) | Sun Q.-Y.; Ding L.-W.; Tan K.-T.; Chien W.; Mayakonda A.; Lin D.-C.; Loh X.-Y.; Xiao J.-F.; Meggendorfer M.; Alpermann T.; Garg M.; Lim S.-L.; Madan V.; Hattori N.; Nagata Y.; Miyano S.; Yeoh A.E.J.; HSIN-AN HOU ; Jiang Y.-Y.; Takao S.; Liu L.-Z.; Tan S.-Z.; Lill M.; Hayashi M.; Kinoshita A.; Kantarjian H.M.; Kornblau S.M.; Ogawa S.; Haferlach T.; Yang H.; Koeffler H.P. | Leukemia | 56 | 52 | |
84 | 2017 | Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish | Lu J.-W.; Hsieh M.-S.; HSIN-AN HOU ; Chen, Chien-Yuan ; HWEI-FANG TIEN ; LIANG-IN LIN | Blood Cancer Journal | 33 | 28 | |
85 | 2023 | Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes | Ward, Grace A; Dalton, Robert P; Meyer, Benjamin S; McLemore, Amy F; Aldrich, Amy L; Lam, Nghi B; Onimus, Alexis H; Vincelette, Nicole D; Trinh, Thu Le; Chen, Xianghong; Calescibetta, Alexandra R; Christiansen, Sean M; HSIN-AN HOU ; Johnson, Joseph O; Wright, Kenneth L; Padron, Eric; Eksioglu, Erika A; List, Alan F | International journal of molecular sciences | 4 | 3 | |
86 | 2022 | PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients | Lee, Sze-Hwei; CHIEN-CHIN LIN ; Wei, Chao-Hong; Chang, Ko-Ping; CHANG-TSU YUAN ; CHENG-HONG TSAI ; Liu, Jia-Hao; HSIN-AN HOU ; Tang, Jih-Lu; WEN-CHIEN CHOU ; HWEI-FANG TIEN | The journal of pathology. Clinical research | 1 | 1 | |
87 | 2015 | Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma | Hsiao L.-T.; HWEI-FANG TIEN ; Kuo C.-Y.; Wu J.-H.; HSIN-AN HOU ; Wang M.-C.; Liu C.-Y.; Chen P.-M.; Chiou T.-J. | Hematological Oncology | 1 | 1 | |
88 | 2019 | Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials | Hsu Y.-C.; Chen T.-C.; CHIEN-CHIN LIN ; CHANG-TSU YUAN ; CHIA-LANG HSU ; HSIN-AN HOU ; Kao C.-J.; Chuang P.-H.; Chen Y.-R.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Advances | 23 | 20 | |
89 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 11 | 9 | |
90 | 2009 | Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute | HSIN-AN HOU ; MING YAO ; JIH-LUH TANG ; YIN-KAI CHEN ; BOR-SHENG KO ; Huang S.-Y.; HWEI-FANG TIEN ; HSIU-HAO CHANG ; MENG-YAO LU ; TING TSE LIN ; Lin K.-H.; Hsiao C.-H.; CHUNG-WU LIN ; YAO-CHANG CHEN | Bone Marrow Transplantation | 45 | 38 | |
91 | 2023 | Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML | CHENG-HONG TSAI ; Sun, Kuo-Jui; Lo, Min-Yen; FENG-MING TIEN ; YUAN-YEH KUO ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; Sun, Hsun-I; Liu, Ming-Chih; CHIA-WEN LIU ; CHIEN-CHIN LIN ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 7 | 3 | |
92 | 2022 | A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan | HSIN-AN HOU ; Tang, Chao-Hsiun; Goh, Choo Hua; Shen, Shih-Pei; KUAN-CHIH HUANG ; Qiu, Hong; Siggins, Sarah; Rothwell, Lee Anne; Liu, Yanfang | Scientific reports | 5 | 2 | |
93 | 2023 | Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma | CHANG-TSU YUAN ; ANN-LII CHENG ; HSIN-AN HOU | Virchows Archiv : an international journal of pathology | 0 | 0 | |
94 | 2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
95 | 2014 | Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations | SHENG-CHIEH CHOU ; JIH-LUH TANG ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Hu F.-C.; Chen, Chien-Yuan ; MING YAO ; BOR-SHENG KO ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia Research | 18 | 18 | |
96 | 2018 | The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome | YI-TSUNG YANG ; Chiu, Y.-C.; Kao, C.-J.; HSIN-AN HOU ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; Tseng, M.-H.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 19 | 17 | |
97 | 2016 | Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia | Chiu Y.-C.; MONG-HSUN TSAI ; WEN-CHIEN CHOU ; Liu Y.-C.; Kuo Y.-Y.; HSIN-AN HOU ; TZU-PIN LU ; LIANG-CHUAN LAI ; Chen Y.; HWEI-FANG TIEN ; ERIC YAO-YU CHUANG | Leukemia | 22 | 21 | |
98 | 2011 | Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile | Lin T.-C.; Jiang S.-S.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Lin Y.-M.; Chang C.-L.; Hsu C.-A.; HWEI-FANG TIEN ; LIANG-IN LIN | Journal of Molecular Diagnostics | 13 | 13 | |
99 | 2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
100 | 2022 | Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias | Su, Kuan-Wei; DA-LIANG OU ; Fu, Yu-Hsuan; HWEI-FANG TIEN ; HSIN-AN HOU ; LIANG-IN LIN | Cancer Gene Therapy | 3 | 2 | |
101 | 2023 | Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial | Zeidan, Amer M; Ando, Kiyoshi; Rauzy, Odile; Turgut, Mehmet; Wang, Ming-Chung; Cairoli, Roberto; HSIN-AN HOU ; Kwong, Yok-Lam; Arnan, Montserrat; Meers, Stef; Pullarkat, Vinod; Santini, Valeria; Malek, Kamel; Kiertsman, Flavia; Niolat, Julie; Ramos, Pedro Marques; Menssen, Hans D; Fenaux, Pierre; Miyazaki, Yasushi; Platzbecker, Uwe | The Lancet. Haematology | 3 | 0 | |
102 | 2011 | Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information | WEN-CHIEN CHOU ; HSIN-AN HOU ; Liu C.-Y.; Chen C.-Y.; LIANG-IN LIN ; Huang Y.-N.; Chao Y.-C.; Hsu C.-A.; Huang C.-F.; HWEI-FANG TIEN | Annals of Oncology | 34 | 30 | |
103 | 2015 | SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS | Inoue D.; Kitaura J.; Matsui H.; HSIN-AN HOU ; WEN-CHIEN CHOU ; Nagamachi A.; Kawabata K.C.; Togami K.; Nagase R.; Horikawa S.; Saika M.; Micol J.-B.; Hayashi Y.; Harada Y.; Harada H.; Inaba T.; HWEI-FANG TIEN ; Abdel-Wahab O.; Kitamura T. | Leukemia | 64 | 56 | |
104 | 2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
105 | 2023 | Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia | Sahoo, Binay K; Lin, Yuh-Charn; Tu, Cheng-Fen; CHIEN-CHIN LIN ; Liao, Wei-Ju; Li, Fu-An; Li, Ling-Hui; Mou, Kurt Yun; Roffler, Steve R; Wang, Shu-Ping; Yeh, Chi-Tai; CHI-YUAN YAO ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Yang, Ruey-Bing | Haematologica | 2 | 1 | |
106 | 2022 | Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes | McLemore, Amy F; HSIN-AN HOU ; Meyer, Benjamin S; Lam, Nghi B; Ward, Grace A; Aldrich, Amy L; Rodrigues, Matthew A; Vedder, Alexis; Zhang, Ling; Padron, Eric; Vincelette, Nicole D; Sallman, David A; Abdel-Wahab, Omar; List, Alan F; McGraw, Kathy L | JCI insight | 12 | 10 | |
107 | 2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
108 | 2024 | Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities | WANG-DA LIU ; HSIN-AN HOU ; KO-JEN LI ; Qin, Albert; Tsai, Chan-Yen; WANG-HUEI SHENG | Advances in therapy | 0 | 0 | |
109 | 2022 | SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia | Verstovsek, Srdan; Komatsu, Norio; Gill, Harinder; Jin, Jie; Lee, Sung-Eun; HSIN-AN HOU ; Sato, Toshiaki; Qin, Albert; Urbanski, Raymond; Shih, Weichung; Zagrijtschuk, Oleh; Zimmerman, Craig; Mesa, Ruben A | Future oncology (London, England) | 21 | 11 | |
110 | 2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 256 | 235 | |
111 | 2023 | A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia | Wang, Yu-Hung; CHI-YUAN YAO ; CHIEN-CHIN LIN ; Gurashi, Kristian; Amaral, Fabio M R; Bossenbroek, Hasse; Jerez, Andres; Somervaille, Tim C P; Binder, Moritz; Patnaik, Mrinal M; HSIN-AN HOU ; WEN-CHIEN CHOU ; Batta, Kiran; Wiseman, Daniel H; HWEI-FANG TIEN | British journal of haematology | 0 | 0 | |
112 | 2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 113 | 111 | |
113 | 2020 | TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype | Sallman D.A.; McLemore A.F.; Aldrich A.L.; Komrokji R.S.; McGraw K.L.; Dhawan A.; Geyer S.; HSIN-AN HOU ; Eksioglu E.A.; Sullivan A.; Warren S.; MacBeth K.J.; Meggendorfer M.; Haferlach T.; Boettcher S.; Ebert B.L.; Al Ali N.H.; Lancet J.E.; Cleveland J.L.; Padron E.; List A.F. | Blood | 106 | 95 | |
114 | 2023 | TP53 status and impact on AML prognosis within the ELN 2022 risk classification | Fleming, Shaun; Tsai, Xavier Cheng-Hong; Morris, Rhiannon; HSIN-AN HOU ; Wei, Andrew H | Blood | 2 | 0 | |
115 | 2020 | Treatment evolution and improved survival in multiple myeloma in Taiwan | Tang C.-H.; HSIN-AN HOU ; KUAN-CHIH HUANG ; Qiu H.; Liu Y. | Annals of Hematology | 10 | ||
116 | 2021 | Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan | Liu Y.; Tang C.-H.; Qiu H.; Siggins S.; HSIN-AN HOU | Scientific Reports | 4 | 2 | |
117 | 2023 | Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification | WAN-HSUAN LEE ; Tsai, Ming-Tao; Tsai, Cheng-Hong; FENG-MING TIEN ; Lo, Min-Yen; Tseng, Mei-Hsuan; Kuo, Yuan-Yeh; Liu, Ming-Chih; YI-TSUNG YANG ; JUI-CHE CHEN ; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 3 | 0 | |
118 | 2023 | Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia | Lo, Min-Yen; Tsai, Xavier Cheng-Hong; CHIEN-CHIN LIN ; FENG-MING TIEN ; Kuo, Yuan-Yeh; WAN-HSUAN LEE ; Peng, Yen-Ling; Liu, Ming-Chih; Tseng, Mei-Hsuan; Hsu, Cheng-An; JUI-CHE CHEN ; LIANG-IN LIN ; Sun, Hsun-I; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 6 | 4 | |
119 | 2010 | WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system | HSIN-AN HOU ; TAI-CHUNG HUANG ; LIANG-IN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 142 | 137 |